Steatosis in donor and transplant liver biopsies

Human Pathology

Volumn 31, Issue 10, 2000, Pages 1209-1213

  Crowley, Heather ^a,b   Lewis, W David ^a,b   Gordon, Fredric ^a,b   Jenkins, Roger ^a,b   Khettry, Urmila ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Allograft; Fatty change; Liver

Indexed keywords

ARTICLE; BILE FLOW; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HUMAN TISSUE; INFECTION RISK; LIVER TRANSPLANTATION; ORGAN DONOR; STEATOSIS;

EID: 0033754053     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2000.18473     Document Type: Article

References (17)

1. Fatty liver and lesions in the alcoholic
2. General aspects of drug-induced liver disease
3. Use of livers with microvesicular fat safely expands the donor pool
4. Frozen section evaluation of donor livers before transplantation
5. Hepatic steatosis in liver transplant donors: Common feature of donor population?
6. The outcome of steatotic grafts in liver transplantation
7. Use of fatty donor liver is associated with diminished early patient and graft survival
8. Risk factors for primary dysfunction after liver transplantation: A multivariate analysis
9. Fatty liver disease in morbid obesity
10. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
11. The predictive value of donor liver biopsies in the development of primary non-function after orthotopic liver transplantation
12. Primary nonfunction of hepatic allografts with pre-existing fatty infiltration
13. Liver in obesity
14. Hepatitis C after orthotopic liver transplantation
15. Recurrent and acquired hepatitis C viral infection in liver transplant recipients
16. Recurrent hepatitis C in liver allografts: Early histologic indicators
17. Insulin requirements after liver transplantation and FK-506 immunosuppression